SA
PFE icon

Seneschal Advisors’s Pfizer PFE Stock Holding History

Seneschal Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34K Hold
97
– – ﹤0.01% 184
2026
Q1 		$2.73K Hold
97
– – ﹤0.01% 173
2025
Q4 		$2.42K Buy
97
+50
+106% +$1.26K ﹤0.01% 178
2025
Q3 		$1.2K Buy
+47
New +$1.16K ﹤0.01% 217

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Seneschal Advisors's PFE Position: Q2 2026 in Review

Seneschal Advisors held its Pfizer (PFE) position steady in Q2 2026 at 97 shares worth $2.34K. The position accounts for ﹤0.01% of the portfolio, ranked #184.

Seneschal Advisors first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.73K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Seneschal Advisors held 97 shares of Pfizer worth $2.34K as of Q2 2026.
  • Seneschal Advisors left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up ﹤0.01% of Seneschal Advisors's portfolio in Q2 2026, its #184 holding.
  • Seneschal Advisors first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • Seneschal Advisors's Pfizer position peaked at $2.73K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.